Skip to main content
. 2019 Mar 8;19:56. doi: 10.1186/s12872-019-1039-x

Table 1.

Baseline demographic and clinical characteristics of patient by genre

Overall Males (N = 52) Females (N = 37) p-value
Mean/ Median/ Number SD/IQR/(%) Mean/ Median/ Number SD/IQR/(%) Mean/ Median/ Number SD/IQR/(%)
Age (years) 65.0 61.2–68.1 64.4 59.4–68.4 65.9 62.3–67.9 0.474
BMI (Kg/m2) 29.4 4.2 29.2 4.4 29.6 4.1 0.693
Office systolic blood pressure (mmHg) 132.6 16.4 130.9 17.0 135.0 15.5 0.241
Office diastolic blood pressure (mmHg) 80.5 9.0 79.5 9.0 82.0 9.0 0.200
Pulse pressure (mmHg) 51.5 41.3–59.3 49.8 40.5–56.3 53.0 42.5–63.3 0.589
Heart rate (beats/min) 72.3 11.8 72.0 12.1 72.8 11.6 0.736
Smoker n (%) 9 10.1 3 5.8 6 16.2 0.388
Physical activity (METS-min/week) 1605.0 777.5–2785.5 1696.0 930.8–2928.8 1406.0 516.0–2772.0 0.098
Intensity of the walk 0.816
 - Low 42 47.2 24 46.2 18 48.6
 - High 47 52.8 28 53.8 19 51.4
Hypertensive n (%) 47 52.8 30 57.7 17 45.9 0.274
Dyslipemic n (%) 53 59.6 32 61.5 21 56.8 0.205
HbA1c % 6.6 6.0–7.3 6.5 6.0–7.4 6.8 6.0–7.3 0.983
Serum glucose (mg/dl) 118.0 100.0–138.0 115.5 96.0–135.5 128.0 104.5–145.5 0.141
Total Cholesterol (mg/dl) 179.7 27.92 184.4 24.1 173.0 31.7 0.056
Triglycerides (mg/dl) 110.0 82.5–140.0 109.0 76.0–141.0 113.0 85.0–140.5 0.736
HDL Cholesterol (mg/dl) 55.0 14.2 55.3 14.5 54.5 13.9 0.801
LDL Cholesterol (mg/dl) 102.5 26.9 106.6 24.3 96.6 29.6 0.084
Antihypertensive drugs n (%) 46 51.7 28 53.8 18 48.6 0.234
Lipidlowering drugs n (%) 52 58.4 28 53.8 24 64.9 0.299
Antidiabetic drugs n(%) 81 91.0 46 88.5 35 94.6 0.319

Values are means [standard deviations (SD)] for normally distributed continuous data and medians (interquartile range) for asymmetrically distributed continuous data

BMI Body mass index, METs Metabolic equivalent, HbA1c hemoglobin A1c, HDL high-density lipoprotein, LDL low-density lipoprotein, SD Standard Deviation, IQR Interquartile Range